Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124639063 | 12463906 | 3 | F | 201602 | 20160628 | 20160614 | 20160712 | EXP | US-ACORDA-ACO_123525_2016 | ACORDA | 64.92 | YR | F | Y | 88.44000 | KG | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124639063 | 12463906 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, QD | Y | U | OH105V | 22250 | 10 | MG | TABLET | QD | |||
| 124639063 | 12463906 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Y | U | 22250 | TABLET | |||||||||
| 124639063 | 12463906 | 3 | SS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 20 MG, 3X/WK | 0 | 20 | MG | TIW | |||||||
| 124639063 | 12463906 | 4 | SS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 40 MG, 3X/WK | 0 | 40 | MG | TIW | |||||||
| 124639063 | 12463906 | 5 | C | ELIQUIS | APIXABAN | 1 | UNK | U | 0 | ||||||||||
| 124639063 | 12463906 | 6 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | UNK | U | 0 | ||||||||||
| 124639063 | 12463906 | 7 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | UNK | U | 0 | ||||||||||
| 124639063 | 12463906 | 8 | C | MELOXICAM. | MELOXICAM | 1 | UNK, PRN | U | 0 | ||||||||||
| 124639063 | 12463906 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
| 124639063 | 12463906 | 10 | C | OXYBUTYNIN CHLORIDE. | OXYBUTYNIN CHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 124639063 | 12463906 | 11 | C | CRANBERRY. | CRANBERRY | 1 | UNK | U | 0 | ||||||||||
| 124639063 | 12463906 | 12 | C | NUVIGIL | ARMODAFINIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 124639063 | 12463906 | 13 | C | NEURONTIN | GABAPENTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124639063 | 12463906 | 14 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 124639063 | 12463906 | 15 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124639063 | 12463906 | 1 | Multiple sclerosis |
| 124639063 | 12463906 | 2 | Gait disturbance |
| 124639063 | 12463906 | 3 | Multiple sclerosis |
| 124639063 | 12463906 | 5 | Product used for unknown indication |
| 124639063 | 12463906 | 6 | Product used for unknown indication |
| 124639063 | 12463906 | 7 | Product used for unknown indication |
| 124639063 | 12463906 | 8 | Product used for unknown indication |
| 124639063 | 12463906 | 9 | Product used for unknown indication |
| 124639063 | 12463906 | 10 | Product used for unknown indication |
| 124639063 | 12463906 | 11 | Product used for unknown indication |
| 124639063 | 12463906 | 12 | Product used for unknown indication |
| 124639063 | 12463906 | 13 | Product used for unknown indication |
| 124639063 | 12463906 | 14 | Product used for unknown indication |
| 124639063 | 12463906 | 15 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124639063 | 12463906 | Drug ineffective | |
| 124639063 | 12463906 | Inflammation | |
| 124639063 | 12463906 | Injection site erythema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124639063 | 12463906 | 1 | 2014 | 0 | ||
| 124639063 | 12463906 | 3 | 1999 | 0 |